FDA Issues Draft Guidances on Drug Errors, Bioequivalence
By Staff Reports
Monday, December 17, 2012
The FDA has issued a draft guidance: "Safety Considerations for Product Design to Minimize Medication Errors" that provides drug sponsors with a set of principles for developing drug products using a systems approach to minimize medication errors relating to product design.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.